Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia

* Goal: This study is a randomized phase II interventional study. The purpose of this study is to see if addition of oral rifaximin tablets during allogeneic stem cell transplant can improve the quality of gut microbiome and reduce chances of death, infections and graft versus host disease (GVHD) post-transplant. * The study objectives are as follows: * Primary Objective: To determine the impact of rifaximin on gut microbial diversity and compare it with controls. * Secondary Objectives: a. To determine non-relapse mortality at 1-year post transplant in patients who receive peri-transplant tra

Trial Details

NCT ID
NCT06058572
Phase
PHASE2
Sponsor
Tata Memorial Centre
Status
RECRUITING
Cancer Type
Leukemia
Interventions
  • Rifaximin 200Mg Tab
  • allogenic hematopoietic stem cell transplantation
Locations (sample)
  • Navi Mumbai, Maharashtra, India|19.03681,73.01582

Key Eligibility Criteria

  • Adults with acute leukemia undergoing allogeneic stem cell transplant.
  • ECOG performance status 0, 1 or 2.
  • Adequate Liver function

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Leukemia Trials on Trialify →